Greenwich Total Assets vs Total Current Assets Analysis

GLSI Stock  USD 13.51  0.30  2.27%   
Greenwich Lifesciences financial indicator trend analysis is much more than just examining Greenwich Lifesciences latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Greenwich Lifesciences is a good investment. Please check the relationship between Greenwich Lifesciences Total Assets and its Total Current Assets accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Greenwich Lifesciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
For more detail on how to invest in Greenwich Stock please use our How to Invest in Greenwich Lifesciences guide.

Total Assets vs Total Current Assets

Total Assets vs Total Current Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Greenwich Lifesciences Total Assets account and Total Current Assets. At this time, the significance of the direction appears to have totally related.
The correlation between Greenwich Lifesciences' Total Assets and Total Current Assets is 1.0. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Total Current Assets in the same time period over historical financial statements of Greenwich Lifesciences, assuming nothing else is changed. The correlation between historical values of Greenwich Lifesciences' Total Assets and Total Current Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of Greenwich Lifesciences are associated (or correlated) with its Total Current Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Assets has no effect on the direction of Total Assets i.e., Greenwich Lifesciences' Total Assets and Total Current Assets go up and down completely randomly.

Correlation Coefficient

1.0
Relationship DirectionPositive 
Relationship StrengthVery Strong

Total Assets

Total assets refers to the total amount of Greenwich Lifesciences assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Greenwich Lifesciences books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Assets

The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.
Most indicators from Greenwich Lifesciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Greenwich Lifesciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Greenwich Lifesciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
For more detail on how to invest in Greenwich Stock please use our How to Invest in Greenwich Lifesciences guide.The Greenwich Lifesciences' current Enterprise Value is estimated to increase to about 240.3 M, while Selling General Administrative is projected to decrease to under 1.2 M.
 2021 2023 2024 (projected)
Reconciled Depreciation3.6K4.2K4.0K
Total Operating Expenses4.6M9.3M5.3M

Greenwich Lifesciences fundamental ratios Correlations

-0.15-0.210.95-0.040.77-1.0-0.37-0.231.0-0.551.00.410.62-0.70.84-0.710.951.00.740.98-0.550.76-0.830.85-0.83
-0.150.9-0.220.27-0.410.150.550.54-0.150.55-0.15-0.65-0.510.29-0.40.3-0.22-0.15-0.32-0.20.55-0.340.45-0.440.45
-0.210.9-0.230.33-0.430.220.560.82-0.220.54-0.22-0.5-0.560.19-0.410.2-0.23-0.22-0.26-0.260.54-0.30.52-0.50.52
0.95-0.22-0.23-0.280.91-0.96-0.6-0.250.95-0.750.950.630.77-0.880.95-0.881.00.950.890.98-0.750.9-0.920.94-0.92
-0.040.270.33-0.28-0.580.060.830.58-0.050.72-0.05-0.65-0.760.47-0.440.48-0.28-0.05-0.46-0.210.72-0.450.43-0.450.43
0.77-0.41-0.430.91-0.58-0.78-0.87-0.460.77-0.950.770.830.92-0.930.99-0.930.910.770.950.84-0.950.96-0.980.98-0.98
-1.00.150.22-0.960.06-0.780.380.24-1.00.56-1.0-0.42-0.630.71-0.850.71-0.96-1.0-0.74-0.990.56-0.770.84-0.860.84
-0.370.550.56-0.60.83-0.870.380.58-0.370.98-0.37-0.91-0.90.79-0.790.8-0.6-0.37-0.8-0.490.98-0.80.8-0.790.8
-0.230.540.82-0.250.58-0.460.240.58-0.230.52-0.23-0.32-0.660.12-0.380.13-0.25-0.23-0.2-0.320.52-0.240.5-0.490.5
1.0-0.15-0.220.95-0.050.77-1.0-0.37-0.23-0.551.00.410.62-0.70.84-0.710.951.00.740.98-0.550.76-0.830.85-0.83
-0.550.550.54-0.750.72-0.950.560.980.52-0.55-0.55-0.93-0.920.88-0.90.89-0.75-0.55-0.9-0.641.0-0.910.9-0.890.9
1.0-0.15-0.220.95-0.050.77-1.0-0.37-0.231.0-0.550.410.62-0.70.84-0.710.951.00.740.98-0.550.76-0.830.85-0.83
0.41-0.65-0.50.63-0.650.83-0.42-0.91-0.320.41-0.930.410.8-0.860.8-0.860.630.410.850.5-0.930.84-0.760.75-0.76
0.62-0.51-0.560.77-0.760.92-0.63-0.9-0.660.62-0.920.620.8-0.770.85-0.770.770.620.770.74-0.920.79-0.860.89-0.86
-0.70.290.19-0.880.47-0.930.710.790.12-0.70.88-0.7-0.86-0.77-0.941.0-0.88-0.7-0.99-0.750.88-0.980.87-0.880.87
0.84-0.4-0.410.95-0.440.99-0.85-0.79-0.380.84-0.90.840.80.85-0.94-0.940.950.840.960.88-0.90.98-0.990.98-0.99
-0.710.30.2-0.880.48-0.930.710.80.13-0.710.89-0.71-0.86-0.771.0-0.94-0.88-0.71-0.99-0.750.89-0.980.88-0.880.88
0.95-0.22-0.231.0-0.280.91-0.96-0.6-0.250.95-0.750.950.630.77-0.880.95-0.880.950.890.98-0.750.9-0.920.94-0.92
1.0-0.15-0.220.95-0.050.77-1.0-0.37-0.231.0-0.551.00.410.62-0.70.84-0.710.950.740.98-0.550.76-0.830.85-0.83
0.74-0.32-0.260.89-0.460.95-0.74-0.8-0.20.74-0.90.740.850.77-0.990.96-0.990.890.740.77-0.91.0-0.920.91-0.92
0.98-0.2-0.260.98-0.210.84-0.99-0.49-0.320.98-0.640.980.50.74-0.750.88-0.750.980.980.77-0.640.8-0.870.9-0.87
-0.550.550.54-0.750.72-0.950.560.980.52-0.551.0-0.55-0.93-0.920.88-0.90.89-0.75-0.55-0.9-0.64-0.910.9-0.890.9
0.76-0.34-0.30.9-0.450.96-0.77-0.8-0.240.76-0.910.760.840.79-0.980.98-0.980.90.761.00.8-0.91-0.940.93-0.94
-0.830.450.52-0.920.43-0.980.840.80.5-0.830.9-0.83-0.76-0.860.87-0.990.88-0.92-0.83-0.92-0.870.9-0.94-0.991.0
0.85-0.44-0.50.94-0.450.98-0.86-0.79-0.490.85-0.890.850.750.89-0.880.98-0.880.940.850.910.9-0.890.93-0.99-0.99
-0.830.450.52-0.920.43-0.980.840.80.5-0.830.9-0.83-0.76-0.860.87-0.990.88-0.92-0.83-0.92-0.870.9-0.941.0-0.99
Click cells to compare fundamentals

Greenwich Lifesciences Account Relationship Matchups

Greenwich Lifesciences fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets26.7K28.7M27.2M13.5M7.0M6.6M
Other Current Liab646.8K770.3K164.3K42.1K258.9K311.1K
Total Current Liabilities1.4M1.0M385.2K262.9K294.4K545.8K
Total Stockholder Equity(1.4M)27.6M26.8M13.2M6.7M11.5M
Net Debt(6.2K)(28.7M)(27.2M)(13.5M)(7.0M)(7.3M)
Retained Earnings(27.2M)(29.1M)(33.6M)(41.5M)(50.4M)(52.9M)
Cash6.8K28.7M27.2M13.5M7.0M6.6M
Non Current Assets Total19.8K16.2K12.6K9.0K5.4K5.1K
Cash And Short Term Investments6.8K28.7M27.2M13.5M7.0M6.6M
Common Stock Shares Outstanding11.7M12.7M12.9M12.9M12.8M13.8M
Liabilities And Stockholders Equity26.7K28.7M27.2M13.5M7.0M6.6M
Other Stockholder Equity25.9M56.7M60.5M54.7M57.1M49.2M
Total Liab1.4M1.0M385.2K262.9K294.4K279.7K
Net Invested Capital(1.4M)27.6M26.8M13.2M6.7M11.5M
Total Current Assets6.8K28.7M27.2M13.5M7.0M6.6M
Capital Stock10.4K12.7K13.1K12.8K14.8K11.8K
Net Working Capital(1.4M)27.6M26.8M13.2M6.7M13.3M
Intangible Assets19.8K16.2K12.6K9.0K5.4K5.1K
Common Stock8.5K12.7K13.1K12.8K14.8K11.0K

Currently Active Assets on Macroaxis

When determining whether Greenwich Lifesciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Greenwich Lifesciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Greenwich Lifesciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Greenwich Lifesciences Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Greenwich Lifesciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
For more detail on how to invest in Greenwich Stock please use our How to Invest in Greenwich Lifesciences guide.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Greenwich Lifesciences. If investors know Greenwich will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Greenwich Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.81)
Return On Assets
(0.72)
Return On Equity
(1.24)
The market value of Greenwich Lifesciences is measured differently than its book value, which is the value of Greenwich that is recorded on the company's balance sheet. Investors also form their own opinion of Greenwich Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Greenwich Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Greenwich Lifesciences' market value can be influenced by many factors that don't directly affect Greenwich Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Greenwich Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Greenwich Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Greenwich Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.